Search

Our Pipeline
Awards & Recognitions: Sarepta recognized for innovation and industry leadership
Sarepta Therapeutics Announces Pipeline Progress for Multiple Limb-Girdle Muscular Dystrophy Programs
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics to Present at the BofA Securities Health Care Conference
Sarepta Therapeutics to Announce First Quarter 2025 Financial Results
Sarepta Therapeutics Provides Update on ELEVIDYS
Route 79 Scholarship Program
Wearable devices and the future of rare disease clinical trials: Landry’s story
Video: Scholarship Recipients, and Twins, Austin and Connor Travel Route 79 Together